Identification of an anticoagulant peptide that inhibits both fXIa and fVIIa/tissue factor from the blood-feeding nematode Ancylostoma caninum

Biochemical and Biophysical Research Communications

Volumn 392, Issue 2, 2010, Pages 155-159

  Li, Deng ^a   He, Qingfeng ^a   Kang, Tao ^a   Yin, Huan ^a   Jin, Xian ^a   Li, Hui ^a   Gan, Weiqiong ^a   Yang, Chen ^a   Hu, Jingjing ^a   Wu, Yamin ^a   Peng, Lifei ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Ancylostoma caninum; Coagulation; Factor VIIa; Factor XIa; Inhibitor; Tissue factor

Indexed keywords

BLOOD CLOTTING FACTOR 11A; BLOOD CLOTTING FACTOR 7A; PEPTIDE DERIVATIVE; PROTEIN ACANAP10; THROMBOPLASTIN; UNCLASSIFIED DRUG;

ANCYLOSTOMA CANINUM; ARTICLE; BLOOD CLOTTING; DRUG MECHANISM; IC 50; NONHUMAN; NUCLEOTIDE SEQUENCE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTHROMBIN TIME;

AMINO ACID SEQUENCE; ANCYLOSTOMA; ANIMALS; ANTICOAGULANTS; CLONING, MOLECULAR; DNA, COMPLEMENTARY; FACTOR VII; FACTOR XIA; HUMANS; MOLECULAR SEQUENCE DATA; PARTIAL THROMBOPLASTIN TIME; PEPTIDES; PROTHROMBIN TIME;

ANCYLOSTOMA CANINUM;

EID: 75749103376     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.12.177     Document Type: Article

References (39)

1. Butenas S., and Mann K.G. Blood coagulation. Biochemistry (Mosc.) 67 (2002) 3-12
2. Vine A.K. Recent advances in haemostasis and thrombosis. Retina 29 (2009) 1-7
3. Fujikawa K. Historical perspective of factor XI. Thromb. Res. 115 (2005) 441-450
4. Kirchhofer D., and Nemerson Y. Initiation of blood coagulation: the tissue factor/factor VIIa complex. Curr. Opin. Biotechnol. 7 (1996) 386-391
5. Broze Jr. G.J., Girard T.J., and Novotny W.F. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry 29 (1990) 7539-7546
6. Broze Jr. G.J. Tissue factor pathway inhibitor and the revised theory of coagulation. Annu. Rev. Med. 46 (1995) 103-112
7. Gailani D., and Broze Jr. G.J. Factor XI activation in a revised model of blood coagulation. Science 253 (1991) 909-912
8. Naito K., and Fujikawa K. Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. J. Biol. Chem. 266 (1991) 7353-7358
9. Matafonov A., Tucker E.I., Sun M.F., Walsh P.N., Gruber A., and Gailani D. Factor XI contributes to thrombin generation in the absence of factor XII. Blood 114 (2009) 452-458
10. von dem Borne P.A., Meijers J.C., and Bouma B.N. Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis. Blood 86 (1995) 3035-3042
11. von dem Borne P.A., Bajzar L., Meijers J.C., Nesheim M.E., and Bouma B.N. Thrombin-mediated activation of factor XI results in a TAFI (thrombin activatable fibrinolysis inhibitor) dependent inhibition of fibrinolysis. J. Clin. Invest. 99 (1997) 2323-2327
12. von dem Borne P.A., Cox L.M., and Bouma B.N. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor. Blood Coagul. Fibrinolysis 17 (2006) 251-257
13. Bouma B.N., and Meijers J.C. Role of blood coagulation factor XI in downregulation of fibrinolysis. Curr. Opin. Hematol. 7 (2000) 266-272
14. Francischetti I.M., Mather T.N., and Ribeiro J.M. Penthalaris, a novel recombinant five-Kunitz tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick vector of Lyme disease, Ixodes scapularis. Thromb. Haemost. 91 (2004) 886-898
15. Francischetti I.M., Valenzuela J.G., Andersen J.F., Mather T.N., and Ribeiro J.M. Ixolaris, a novel recombinant tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick, Ixodes scapularis: identification of factor X and factor Xa as scaffolds for the inhibition of factor VIIa/tissue factor complex. Blood 99 (2002) 3602-3612
16. Stassens P., Bergum P.W., Gansemans Y., Jespers L., Laroche Y., Huang S., Maki S., Messens J., Lauwereys M., Cappello M., Hotez P.J., Lasters I., and Vlasuk G.P. Anticoagulant repertoire of the hookworm Ancylostoma caninum. Proc. Natl. Acad. Sci. USA 93 (1996) 2149-2154
17. Mieszczanek J., Harrison L.M., Vlasuk G.P., and Cappello M. Anticoagulant peptides from Ancylostoma caninum are immunologically distinct and localize to separate structures within the adult hookworm. Mol. Biochem. Parasitol. 133 (2004) 319-323
18. Weitz J.I., Hirsh J., and Samama M.M. American college of chest physicians, new antithrombotic drugs: American college of chest physicians evidence-based clinical practice guidelines (eighth ed.). Chest 133 (2008) 234S-256S
19. Lee A.Y.Y., and Vlasuk G.P. Recombinant nematode anticoagulant protein c2 and other inhibitors targeting blood coagulation factor VIIa/tissue factor. J. Intern. Med. 254 (2003) 313-321
20. Nazareth R.A., Tomaz L.S., Ortiz-Costa S., Atella G.C., Ribeiro J.M., Francischetti I.M., and Monteiro R.Q. Antithrombotic properties of Ixolaris, a potent inhibitor of the extrinsic pathway of the coagulation cascade. Thromb. Haemost. 96 (2006) 7-13
21. Roche M., and Layrisse M. The nature and causes of hookworm anemia. Am. J. Trop. Med. Hyg. 15 (1966) 1029-1102
22. Del Valle A., Jones B.F., Harrison L.M., Chadderdon R.C., and Cappello M. Isolation and molecular cloning of a secreted hookworm platelet inhibitor from adult Ancylostoma caninum. Mol. Biochem. Parasitol. 129 (2003) 167-177
23. Harrison L.M., Nerlinger A., Bungiro R.D., Córdova J.L., Kuzmic P., and Cappello M. Molecular characterization of Ancylostoma inhibitors of coagulation factor Xa. Hookworm anticoagulant activity in vitro predicts parasite bloodfeeding in vivo. J. Biol. Chem. 277 (2002) 6223-6629
24. Mieszczanek J., Harrison L.M., and Cappello M. Ancylostoma ceylanicum anticoagulant peptide-1: role of the predicted reactive site amino acid in mediating inhibition of coagulation factors Xa and VIIa. Mol. Biochem. Parasitol. 137 (2004) 151-159
25. Gan W., Deng L., Yang C., He Q., Hu J., Yin H., Jin X., Lu C., Wu Y., and Peng L. An anticoagulant peptide from the human hookworm, Ancylostoma duodenale that inhibits coagulation factors Xa and XIa. FEBS Lett. 583 (2009) 1976-1980
26. Cappello M., Vlasuk G.P., Bergum P.W., Huang S., and Hotez P.J. Ancylostoma caninum anticoagulant peptide: a hookworm-derived inhibitor of human coagulation factor Xa. Proc. Natl. Acad. Sci. USA 92 (1995) 6152-6156
27. Buddai S.K., Toulokhonova L., Bergum P.W., Vlasuk G.P., and Krishnaswamy S. Nematode anticoagulant protein c2 reveals a site on factor Xa that is important for macromolecular substrate binding to human prothrombinase. J. Biol. Chem. 277 (2002) 26689-26698
28. Bergum P.W., Cruikshank A., Maki S.L., Kelly C.R., Ruf W., and Vlasuk G.P. Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2. J. Biol. Chem. 276 (2001) 10063-10071
29. Cawthern K.M., van't Veer C., Lock J.B., DiLorenzo M.E., Branda R.F., and Mann K.G. Blood coagulation in hemophilia A and hemophilia C. Blood 91 (1998) 4581-4592
30. Gomez K., and Bolton-Maggs P. Factor XI deficiency. Haemophilia 14 (2008) 1183-1189
31. Renné T., Oschatz C., Seifert S., Müller F., Antovic J., Karlman M., and Benz P.M. Factor XI deficiency in animal models. J. Thromb. Haemost. 7 (2009) S79-83
32. Yamashita A., Nishihira K., Kitazawa T., Yoshihashi K., Soeda T., Esaki K., Imamura T., Hattori K., and Asada Y. Factor XI contributes to thrombus propagation on injured neointima of the rabbit iliac artery. J. Thromb. Haemost. 4 (2006) 1496-1501
33. Tucker E.I., Marzec U.M., White T.C., Hurst S., Rugonyi S., McCarty O.J., Gailani D., Gruber A., and Hanson S.R. Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI. Blood 113 (2009) 936-944
34. Gruber A., and Hanson S.R. Factor XI-dependence of surface- and tissue factor-initiated thrombus propagation in primates. Blood 102 (2003) 953-955
35. Lin J., Deng H., Jin L., Pandey P., Quinn J., Cantin S., Rynkiewicz M.J., Gorga J.C., Bibbins F., Celatka C.A., Nagafuji P., Bannister T.D., Meyers H.V., Babine R.E., Hayward N.J., Weaver D., Benjamin H., Stassen F., Abdel-Meguid S.S., and Strickler J.E. Design, synthesis, and biological evaluation of peptidomimetic inhibitors of factor XIa as novel anticoagulants. J. Med. Chem. 49 (2006) 7781-7791
36. Lazarova T.I., Jin L., Rynkiewicz M., Gorga J.C., Bibbins F., Meyers H.V., Babine R., and Strickler J. Synthesis and in vitro biological evaluation of aryl boronic acids as potential inhibitors of factor XIa. Bioorg. Med. Chem. Lett. 16 (2006) 5022-5027
37. Gailani D., and Renné T. The intrinsic pathway of coagulation: a target for treating thromboembolic disease?. J. Thromb. Haemost. 5 (2007) 1106-1112
38. Smith S.B., and Gailani D. Update on the physiology and pathology of factor IX activation by factor XIa. Expert. Rev. Hematol. 1 (2008) 87-98
39. Schumacher W.A., Seiler S.E., Steinbacher T.E., Stewart A.B., Bostwick J.S., Hartl K.S., Liu E.C., and Ogletree M.L. Antithrombotic and hemostatic effects of a small molecule factor XIa inhibitor in rats. Eur. J. Pharmacol. 570 (2007) 167-174